Eric I Richman Neu Base Therapeutics, Inc. (NBSE) insider trading activity

NBSE Quotes by TradingView

Eric I Richman is Director of NeuBase Therapeutics, Inc.. Currently has a direct ownership of 44,960 shares of NBSE, which is worth approximately $0. The most recent transaction as insider was on Mar 04, 2022, when has been sold 1,000 shares (Common Stock) at a price of $1.62 per share, resulting in proceeds of $1,620. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45K
0% 3M change
0% 12M change
Total Value Held $0

ERIC I RICHMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 04 2022
BUY
Open market or private purchase
$1,620 $1.62 p/Share
1,000 Added 2.18%
44,960 Common Stock
Mar 03 2022
BUY
Open market or private purchase
$2,236 $1.72 p/Share
1,300 Added 2.87%
43,960 Common Stock
Mar 01 2022
BUY
Open market or private purchase
$2,496 $1.58 p/Share
1,580 Added 3.57%
42,660 Common Stock
Apr 26 2021
BUY
Open market or private purchase
$25,000 $5.0 p/Share
5,000 Added 10.85%
41,080 Common Stock

Also insider at

GANX
Gain Therapeutics, Inc. Healthcare
Director
EIR

Eric I Richman

Director
Pittsburgh, PA

Track Institutional and Insider Activities on NBSE

Follow NeuBase Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBSE shares.

Notify only if

Insider Trading

Get notified when an Neu Base Therapeutics, Inc. insider buys or sells NBSE shares.

Notify only if

News

Receive news related to NeuBase Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBSE